acids (Funkenstein et al., 1984; Amsterdam and Rotmensch, 1987) .
The mechanisms underlying the alteration of gene expression in luteinizing granulosa cells are not completely understood. It has been reported (Pall et al., 1997; Sterneck et al., 1997; Löhrke et al., 1998) that transcription factors are involved, which mediate the transduction of hormonal signals, including those arising from lipids, to targets at the DNA. A group of transcription factors, the peroxisome proliferator-activated receptors (PPAR) α and γ, are thought to be key regulators in cellular lipid homeostasis (Kliewer et al., 1997) which requires co-ordination between peroxisomes and mitochondria during steroidogenesis (Mendis-Handagama et al., 1995) . PPAR-γ regulates the expression of genes encoding enzymes of the cholesterol synthesis pathway, such as 3-hydroxy-3-methylglutaryl-CoA synthase (Rodriguez et al., 1994) and lipoprotein lipase (Schoonjans et al., 1996) which mediates uptake of fatty acids and cholesterol.
In contrast to PPAR-γ, the expression of PPAR-α is regulated by glucocorticoids (Lemberger et al., 1994) . The transcription factor C/EBP β , a member of the CCAAT enhancer binding protein (C/EBP) family, stimulates the expression of PPAR-γ (Wu et al., 1995) . In turn, the C/EBP β gene is regulated by gonadotrophins and is the only known transcription factor that is induced promptly in response to an ovulatory dose of LH and to the LH surge naturally occurring during ovulation in many species (Pall et al., 1997; Sterneck et al., 1997) . C/EBP β stimulates not only the expression of PPAR-γ but also, in co-operation with C/EBP α , of cyclooxygenase 2, also called prostaglandin endoperoxide synthase 2 (Sirois and Richards, 1993) , which is important in the production of prostaglandins from arachidonic acid metabolism (Reginato et al., 1998) .
PPAR-γ is activated by binding arachidonic acid and type D 2 prostaglandins (Kliewer et al., 1997) of which 15-deoxy-∆ 12,14 PGJ 2 (15dPGJ 2 ) is the most potent (Forman et al., 1995) , whereas PGF 2α antagonizes the action of PPAR-γ via stimulation of phosphorylating pathways (Reginato et al., 1998) . C/EBP forms are expressed in ovarian cells, including in the granulosa layer of preovulatory antral follicles (Piontkewitz et al., 1996; Sterneck et al., 1997) . C/EBP β -deficient ovaries lack corpora lutea and fail to downregulate expression of the prostaglandin endoperoxidase synthase 2 and P450 aromatase genes in response to gonadotrophins (Sterneck et al., 1997) .
A regulatory role of PPAR-γ in the regression of the corpus luteum may occur not only at the intracellular lipid homeostasis but also at the interaction between luteal and non-luteal cells which also express PPAR-γ, including macrophages (Xing et al., 1997) , vascular endothelial and smooth muscle cells (Marx et al., 1998; Satoh et al., 1999) . Activation of PPAR-γ blocks the cell cycle in vascular cells and inhibits the expression of genes encoding vasoconstrictive factors in endothelial cells (Marx et al., 1998; Satoh et al., 1999) . Thus, a high concentration of PPAR-γ may promote the circulatory supply of the corpus luteum, whereas it may prevent vascularization. A decrease in the PPAR-γ proteins due to downregulation of the activity of macrophages by increasing concentrations of progesterone (Sugino et al., 1996) and, as a corollary, a reduction in potent PPAR-γ agonists could result in abrogation of the suppression of vasoconstrictive endothelial activity, leading to circulatory malfunction and, therefore, to functional regression. There are two isoforms of the PPAR-γ protein: PPAR-γ 1 and PPAR-γ 2 (Forman et al., 1995; Kliewer et al., 1995) . Three PPAR-γ mRNAs (γ 1 , γ 2 and γ 3 ) give rise to two proteins; the translation products of γ 1 and γ 3 mRNA are indistinguishable (Fajas et al., 1998) . Little is known about the function of the two proteins transcribed from the PPAR-γ gene because detailed side by side comparison of activation by the transcription factors PPAR-γ 1 and -γ 2 has not been performed in mammalian cells (Fajas et al., 1998) , including those from the corpus luteum.
To date, there has only been one study on the expression and function of PPAR-γ proteins in lutein cells Löhrke et al. (1998) . The known functions of PPAR-γ in non-luteal cells listed above indicate a role of the transcription factor in the co-ordinated development of the cellular metabolic compartments that provide lutein cells with substrates for steroidogenesis. Enhanced steroidogenesis is accompanied by a loss of lutein cell cycle activity (Fields et al., 1992) . The steroidogenesis ceases and the corpus luteum regresses when fertilization does not take place. The corresponding regulatory events are poorly understood. It is hypothesized that the expression rate of PPAR-γ is linked to the developmental stages of the corpus luteum. Hence, in the present study, the expression of PPAR-γ protein in relation to the cell cycle activity during different stages of the corpus luteum was investigated.
Materials and Methods

Materials
PPAR-γ antibodies to the amino acid sequence 284-298 of the PPAR-γ protein were purchased from Cayman-Alexis (Grünberg). Standards beads for the calibration of fluorescence intensities were obtained from FCSC (Leiden). All other chemicals, hormones and antibodies were from Sigma (Deisenhofen), unless stated otherwise.
Animals
Dairy heifers at 18-20 months old and weighing between 430 and 470 kg were used in the experiments. Heifers with a regular oestrous cycle (day 5, day 12, day 20, oestrus = day 0) were used. Detection of oestrus was performed twice a day. In addition, rectal palpation of the ovaries and ultrasonic diagnosis were conducted to gain more information on the stage of the oestrous cycle.
Pregnant heifers (day 0 = oestrus + artificial insemination) were killed on days 5, 12 and 20 (three animals on each day).
Lutein cell preparation
Corpora lutea were obtained by ovariectomy performed on days 5, 12 and 20 (three animals on each day) of the oestrous cycle (oestrus = day 0) in cows anaesthetized by epidural and local anaesthesia in accordance with the German Federal Law for Care of Animals. In experiments to test the effect of PGF 2α on PPAR-γ expression, the animals were treated on day 4 with cloprostenol (aniMedica, Bernburg) at a dose of 1.4 µg kg -1 and corpora lutea were collected after 12 h. Functional regression was confirmed by measuring the progesterone concentration, which decreased significantly (1.4-fold the carrier-treated control, P < 0.05) in response to the drug. The corpora lutea were surgically removed from the ovaries and were dissociated mechanically to minimize the contamination of lutein cells with other types of cell expressing PPAR-γ. The number of lutein cells per mass of corpus luteum on days 5 and 12 was 6.9 × 10 5 and 3.8 × 10 5 cells g -1 , respectively. More rigorous dissociation using both mechanical and enzymatic techniques did not yield significantly greater numbers of lutein cells. The tissue was placed on gauze (40 µm pores), minced, and gently ground using a glass rod, covering the tissue with Ham's F12 medium buffered with Hepes (25 mmol l -1 , pH 7.4) and containing 2 mmol EDTA l -1 to facilitate cell dissociation. The cell suspension was filtered, the cells were separated by centrifugation (200 g, 10 min), and the erythrocytes were lysed by resuspending the cells in water. The lysis was stopped after 10 s by the addition of concentrated saline to achieve 0.85% (w/v) saline. After centrifugation, the cells were resuspended in serum-free EDTA-free Hepes-buffered Ham's F12 medium with 10 ng insulin ml -1 (culture medium). The proportions of large and small lutein cells separated by flow cytometry were 60 ± 10 and 25 ± 8% of the total cellular counts used in culture. In the analysis, the percentage of large lutein cells increased > 95% by gating the cells in the flow cytometric histogram. Cell density was determined using a cell counter (Coulter, Krefeld) and cell viability by exclusion of trypan blue or 40 µmol propidium iodide l -1 . Uptake of propidium iodide was checked by flow cytometry; the viability was > 95%.
Flow cytometry
Quantitative analysis of cellular fluorescence was performed by flow cytometry to analyse the cells simultaneously according to size, granularity, LH receptors and PPAR-γ expression (proportion of cells expressing PPAR-γ, and PPAR-γ content per cell). The analysis of LH receptors was carried out according to the method of Fields et al. (1992) and the flow cytometric analysis was conducted as described by Löhrke et al. (1997) . Briefly, an argon laserequipped flow cytometer (Coulter-Elite, Krefeld) recording emissions of multiple fluorescence (green, orange, red) excited at 488 nm (counting 5000 cells) was used. Cells of interest were identified by three successive steps: (i) by establishing a histogram on the basis of cell size and granularity; (ii) by establishing the fluorescence histogram; and (iii) by projecting the fluorescence into the size-granularity histogram. The cells were gated and the proportion of cells and their fluorescence intensity arising from a second fluorogenic label were automatically calculated.
Cell cycle analysis by flow cytometry
Freshly prepared and cultured cells (days 5, 12 and 20 of the oestrous cycle) were used. The cultured cells were incubated for 24 h at 37°C in culture medium with the solvent and with the effectors 15dPGJ 2 and ATA. A stock solution of 15dPGJ 2 dissolved in methylacetate was diluted with 5 mmol sodium phosphate l -1 (pH 7.1) and ATA was dissolved in 50 mmol NaHCO 3 l -1 . The solutions were added (1 volume to 20 volumes of the culture medium) in final concentrations of 200 and 490 nmol 15dPGJ 2 l -1 (0.01% (v/v) methylacetate) and 10 µmol ATA l -1 . Freshly prepared and cultured cells were fixed in ethanol (70%), washed and treated with RNAse solution (100 U ml -1 in PBS, 37°C, 30 min). The RNAse solution was heated (85°C, 60 min) to denature DNAse contamination (Stöhr et al., 1978) . After incubation for 30 min with propidium iodide (70 µmol l ), flow cytometry was performed (Coulter-Elite) and the cell cycle was analysed using a computer-aided multicycle program (Phoenix of the program package of the flow cytometer).
Detection of proliferating cell nuclear antigen
Cells were fixed in ethanol (70%, v/v), washed and treated with RNAase (1 mg ml -1 in PBS, 37°C, 30 min) as described above. The cells were incubated with purified monoclonal IgG 2a mouse antibody against PCNA (final concentration 5 µg ml -1 ) in the dark for 1 h at room temperature. The antibody was conjugated with fluorescein isothiocyanate isomer (FITC). A negative control was obtained by incubating the cells with an non-specific mouse IgG 2a -FITC conjugate (final concentration 5 mg l -1 ; both antibodies from DAKO, Hamburg). After incubation, the cells were washed by centrifugation at 350 g for 5 min, re-suspended with DNA staining medium (propidium iodide, 70 µmol l -1 , in HBS) and incubated in the dark for 30 min at room temperature. After washing and centrifugation at 350 g for 5 min, the cells were resuspended in HBS and the dual fluorescence was analysed by flow cytometry.
PPAR-γ immunofluorescence
Lutein cells were fixed in methanol (-20°C) for 4 min, using one volume of cell suspension and ten volumes of methanol. The cells were centrifuged (150 g, 4°C, 5 min), re-suspended in PBS containing 0.2% (w/v) BSA (pH 7.4) and aliquots were plated (24-well plastic microplates). The cells were incubated (1 h, 22°C) with rabbit-anti-PPAR-γ antibodies used in a final concentration of 2.5 µg ml -1 . The unbound antibodies were washed out and the cells were incubated for 1 h at 22°C with phycoerythrine-conjugated anti-rabbit F(ab') 2 antibody fragments (PBS, pH 7.2, 0.2% (w/v) BSA) or with FITC-conjugated anti-rabbit-F(ab') 2 antibody fragments (PBS, pH 7.4, 0.2 % (w/v) BSA). After washing by centrifugation at 150 g, 4°C, 5 min and resuspension in PBS (pH 7.4, 0.2% (w/v) BSA), the cells were analysed by flow cytometry. A control of the non-specific fluorescence was obtained by omitting the PPAR-γ-specific antibody. The corresponding value was automatically subtracted by the flow cytometer and the percentage of fluorescence-positive cells and the fluorescence intensity per cell were recorded. Quantification of the concentration of PPAR-γ was carried out as described by Löhrke et al. (1998) . Briefly, a calibration of the flow cytometric fluorescence intensity by standards beads (p26) was conducted and the fluorescence intensity of the cells was converted into concentrations with the aid of the calibration curve.
Immunoblotting of PPAR-γ 1 and PPAR-γ 2 isoforms
Cells (days 5, 12 and 20 of the oestrous cycle and days 5 and 12 after PGF 2α ) were lysed by cold aqueous 0.1% (w/v) sodium citrate and 0.1% (v/v) Triton-X100, and the lysate was fractionated by centrifugation (240 000 g, 1 h, 4°C). The supernatant of the ultracentrifugate was used immediately in PAGE and the separated proteins were blotted onto nitrocellulose as described by Löhrke et al. (1993) . The nitrocellulose was blocked by horse serum (5%, v/v) and PPAR-γ was detected by rabbit anti-PPAR-γ antibodies dissolved in the blot buffer containing 2.5% (v/v) horse serum and used in a final concentration of 1 µg ml -1 . The nitrocellulose was washed and incubated with peroxidase-conjugated anti-rabbit-F(ab') 2 according to the manufacturer's instructions (Sigma). The stain was developed by diaminobenzidine (0.3%, w/v) and H 2 O 2 (0.01%, v/v) in 100 mmol Tris l -1 , pH 7.2, as described by Löhrke et al. (1993 Löhrke et al. ( , 1998 . The bands were analysed by scanning the blots and densitometry (Herolab program package, Wiesloch).
Statistical analysis
Unless otherwise stated, experimental data are presented as the mean ± SD of duplicate measurements of three independent experiments. ANOVA and Tukey's comparison methods were used for comparisons among multiple means.
Assessment of the significance of differences in relative data was accomplished by a paired t test. Percentage data obtained by flow cytometry were analysed by chi-squared analysis (internal program package of the flow cytometer).
Results
Corpus luteum morphology in relation to the lutein cell cycle
The diameter of the corpus luteum increased from early dioestrus (day 5) to mid-dioestrus (day 12) and decreased with increasing age towards pro-oestrus (day 20) (Fig. 1a-c,  insets) . The results of the cell cycle analysis indicated the highest proportion of cells in S phase occurred on day 5 (16 ± 4%, n = 3). The proportion of cells in S phase decreased on day 12 (6 ± 4%, n = 3) and the lowest proportion was observed on day 20 (3 ± 3%, n = 3) (Fig. 1a-c) .
The agonist of PPAR-γ, 15dPGJ 2 , used at concentrations of 200 and 490 nmol l -1 did not affect the proportion of cells in S phase after incubation of lutein cells on day 12 of the oestrous cycle (Fig. 2) . ATA (10 µmol l -1 ) significantly increased the proportion of cells in S phase (18 ± 1%, P < 0.05, n = 3) after incubation with the drug for 24 h. Activation of PPAR-γ by 15dPGJ 2 inhibited the stimulatory effect of ATA on the percentage of cells in S phase (Fig. 2) .
Relationship between PCNA and cellular DNA content
The expression of PCNA protein was monitored in different phases of the cell cycle by dual fluorescence analysis involving immunostaining of the PCNA protein and the DNA stain arising from propidium iodide (Fig. 3) . Measurement of the DNA content per cell indicated an increase in the proportion of cells in the G0/G1 phase with increasing age of the corpus luteum (Fig. 3) . In this analysis, the control data from days 5 and 12 (three animals in each case) were pooled as they did not differ (Fig. 3) . Quantitative results of the flow cytometric histograms (Fig. 3) are 
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T. Viergutz et al. presented (Table 1 ). The proportions of PCNA-positive cells in the G 0 /G 1 phase relative to the total number of cells in G 0 /G 1 were 30% and 7% in cells from days 5 and 12, respectively, indicating activated G 1 -lutein cells occurred predominantly in the cell pool from day 5. In the analysis of PCNA, non-specific mouse IgG 2a -FITC was used as a negative control (Fig. 3a (quadrant I + II) and Table 1 ; 18 ± 3%, n = 4, two non-pregnant animals per group). In nonpregnant heifers, the proportion of PCNA-positive cells on day 5 was higher (38 ± 4%, n = 3) than the proportion observed on day 12 (Fig. 3b ,c (quadrant I+II), and Table 1 ; 20 ± 3%, n = 3). An ectopic expression of PCNA in lutein cells on day 12 was not detected (Table 1 ) and the expression in cells from non-pregnant heifers on day 20 was not different from the control (data not shown).
Comparison of PPAR-γ protein expression in lutein cells between non-pregnant and pregnant heifers
Flow cytometrical quantification of the PPAR-γ protein in day 5, day 12 and day 20 non-pregnant and pregnant heifers is shown (Fig. 4) . A decrease in the proportion of PPAR-γ-positive cells was detected in large lutein cells of the corpus luteum from non-pregnant heifers on day 5 > day 12 > day 20 (Fig. 4a) . In contrast, the portion of PPAR-γ-positive cells in pregnant heifers only differed significantly between day 5 and day 20 (Fig. 4a) . The number per cell was significantly (P < 0.05, n = 3 ) higher in pregnant heifers compared with non-pregnant heifers (Fig. 4b ). There were marked differences in the cellular PPAR-γ concentration among the different stages of the corpus luteum (Fig. 4b) . The cellular PPAR-γ content of day 5 and day 20 lutein cells decreased from 4.5 ± 0.5 to 1.0 ± 0.8 fmol per cell in pregnant heifers (Fig. 4b) . In non-pregnant heifers, the corresponding values were 3.4 ± 0.3 and 0.5 ± 0.2 fmol per cell.
Detection of PPAR-γ isoforms
Lutein cells express PPAR-γ 1 with a molecular mass of 52 kDa and PPAR-γ 2 with a molecular mass of 56 kDa (Fig. 5) . The results of the analysis of the changes in the molecular pattern of PPAR-γ are also presented (Fig. 5) . The different stages of the corpus luteum are distinguished by an alteration in the ratio of PPAR-γ 1 :PPAR-γ 2 . A decrease in the PPAR-γ 1 isoform is detectable in day 12 large lutein cells (50% of the value on day 5, P < 0.05) of non-pregnant animals (Fig. 5) .
Information about the physiological background of the reduction in the PPAR-γ proteins was obtained by treating 158
T. Viergutz et al. Table 1 . Values with different letters show differences between day of the oestrous cycle within and between the groups of pregnant and non-pregnant animals (P < 0.05). non-pregnant animals on day 4 + 12 h with the PPAR-γ antagonist PGF 2α , as at this stage the cells of the corpus luteum apparently express the complete set of PPAR-γ proteins. The PPAR-γ 1 protein was markedly reduced (40% of the non-treated control value, P < 0.02), whereas the PPAR-γ 2 isoform decreased less markedly (Fig. 5) .
Discussion
PPAR-γ is expressed in numerous tissues albeit at different concentrations (Braissant et al., 1996) . Nunez et al. (1997) reported that mRNA from PPAR is present in oestrogendependent reproductive tissues and PPARs can activate oestrogen-dependent genes. However, this report only provided evidence for the expression of PPAR-α mRNA in granulosa and theca cells of the ovary and in the corpus luteum. Investigations on PPAR-γ expression in female reproductive cells are lacking, except for the study of Löhrke et al. (1998) in which expression of PPAR-γ mRNA and protein was reported in bovine lutein cells. The results also showed that the PPAR-γ proteins are active and are involved in the control of progesterone production, a functional differentiation marker of lutein cells (Murdoch, 1995; Juengel et al., 1995) .
The results of the present study show that the concentration of PPAR-γ proteins differs among different luteal stages. The highest expression of PPAR-γ was observed in the cells at early dioestrus (day 5). This expression decreased during mid-dioestrus (day 12) and during pro-oestrus (day 20). The expression of PPAR-γ was significantly higher in the cells from pregnant heifers, compared with non-pregnant heifers. Information about the pathways mediating the temporal course of the expression of PPAR-γ proteins was obtained by treating animals at early dioestrus with an antagonist to PPAR-γ, PGF 2α (Reginato et al., 1998) . The lutein cells responded with a decrease in the PPAR-γ proteins, especially PPAR-γ 1 , indicating PPAR-γ is a target for the action of the prostaglandin, which is reported to have strong luteolytic activity in many mammalian species (Tsai and Wiltbank, 1998) . These results indicate PPAR-γ has a role in the maintenance of a differentiated state in large lutein cells. In other mammalian cells, both PPAR-γ isoforms are negatively regulated by tumour necrosis factor α (TNF-α) (Zhang et al., 1996) , a cytokine that may be involved in luteolysis (Gaytan et al., 1998) . However, low constitutive expression of PPAR-γ was sufficient to block partially the inhibitory effects of TNF-α on the expression of genes regulated by PPAR-γ (Zhang et al., 1996) . The ratio of the two isoforms of PPAR-γ varies both among species and tissues (Vidal-Puig et al., 1997; Ma et al., 1998) . PPAR-γ 1 has been found in rodents as a minor component in adipose and non-adipose tissues, whereas PPAR-γ 1 mRNA in bovine spleen, lung and ovary was expressed at a higher level than PPAR-γ 2 mRNA (Sundvold et al., 1997) . Ma et al. (1998) suggested that the function of the PPAR-γ 1 and PPAR-γ 2 isoforms in avian oestrogen-responsive uropygial gland was different: PPAR-γ 1 may be involved in peroxisome proliferation, whereas PPAR-γ 2 may be involved in the regulation of lipid metabolism. In contrast, to date, nothing is known about the role of the PPAR-γ isoforms in lutein cell differentiation. Regulation of lutein cell differentiation should involve control of the cell cycle. Studies in domestic ruminants indicate that small (theca-derived) lutein cells proliferate, whereas large (granulosa-derived) lutein cells do not (Sawyer, 1995) . The proliferative activity in bovine lutein steroidogenic cells in different stages of the corpus luteum is incompletely understood (Niswender et al., 1994) . The results of the present study demonstrate that the proportion of large lutein cells in the S phase of the cell cycle that express PCNA decreased during mid-dioestrus (day 12) compared with early dioestrus (day 5). This observation corresponds to the morphological changes in the corpus luteum and with the concentration of PPAR-γ per lutein cell. PPAR-γ exerts an inhibitory effect on transcription factors, such as those of the signal-transducing activators of transcription (STAT) family (Ricote et al., 1998) , and binds cofactors, including members of the src family (Shao et al., 1998) that are involved in regulation of the cell cycle. However, the mode of action of PPAR-γ on the cell cycle in lutein cells remains to be elucidated. A prerequisite for PPAR-γ activities on the transcription of target genes is activation by an agonist, including long chain fatty acids and type PGD 2 prostanoids (Forman et al., 1995; Kliewer et al., 1995) . The most potent PGD 2 derivative, 15dPGJ 2 , is produced by macrophages that also express PPAR-γ (Ricote et al., 1998) and are present in the corpus luteum (Gaytan et al., 1998; Penny et al., 1998; Zhao et al., 1998) . The number of macrophages identified by the surface antigen CD68 is parallel to the functional activity of the human corpus luteum, indicating bi-directional communication between macrophages and steroidogenic cells or regulation of both cell populations of the corpus luteum by a similar mechanism (Gaytan et al., 1998) . The results of the present study indicate that the corresponding signal transduction may be mediated by PPAR-γ. The activity of macrophages may change with changes in the concentrations of activating and suppressing factors, such as interferon τ and progesterone. The steroid is known to act as a potent antagonist of some activities of macrophages, including superoxide production (Sugino et al., 1996) . Hence, a decrease in ovarian production of PPAR-γ agonists appears to reduce the ectopic expression of PPAR-γ in a timedependent manner. However, the action of macrophages on lutein cells, via the potent PPAR-γ agonist 15dPGJ 2 , is unknown, whereas the luteotrophic effects of type D prostaglandins are established in vitro and in vivo (ZelinskiWooten and Stouffer, 1990) .
The present investigation of the effect of 15dPGJ 2 focused on lutein cells at mid-dioestrus since they are thought to contribute most of the circulating progestins, whereas oestrogens disappear from circulation (Park-Sarge et al., 1995) . These cells almost ceased their proliferative activity as demonstrated in the present study and by Fields et al. (1992) . ATA is a drug that stimulates progress of the cell cycle in lutein cells at mid-dioestrus (Löhrke et al., 1998) . In addition, ATA exerts anti-apoptogenic effects on several types of cell (Catchpoole and Stewart, 1994; Posner et al., 1995) including lutein cells (Löhrke et al., 1998; Viergutz et al., 1999) . Hence, the effect of 15dPGJ 2 on cell cycle activity was investigated using the ATA model. The results showed that the PPAR-γ agonist suppresses an ATA-induced increase in the percentage of cells in S phase in a dose-dependent manner. These results indicate the reversibility of the cell cycle arrest in mid-dioestrous cells and a role for PPAR-γ in arresting the cell cycle to maintain the differentiated function of lutein cells.
In summary, the results of the present study demonstrate a downregulation of the expression PPAR-γ and PCNA proteins in large lutein cells of the ageing corpus luteum, indicating a role in the maintenance of differentiated luteal cells. This proposal is supported by the experiments showing that the near arrest of cell cycle activity in lutein cells at middioestrus can be stimulated by ATA and the natural PPAR-γ agonist, 15dPGJ 2 , reverses the response. In addition, the naturally occurring decrease in the percentage of cells expressing PPAR-γ and in the concentration of PPAR-γ per cell can be simulated by exposing lutein cells from early dioestrus to PGF 2α , which acts luteolytically on the middioestrus corpus luteum and inactivates PPAR-γ. The cells respond to the prostanoid by downregulating PPAR-γ, predominantly by decreasing the PPAR-γ 1 protein, indicating that this isoform is a target for the luteolytic action of PGF 2α .
